Levodopa/Carbidopa/Entacapona Kern Pharma

Levodopa, Carbidopa, Entacapone, the active ingredients in Levodopa/Carbidopa/Entacapone Kern Pharma, are a combination product presented as oral tablets for oral use. The formulation provides a dopamine precursor together with enzymes inhibitors to manage Parkinson's disease symptoms in adult patients. It is indicated for continuous symptom control and is prescribed as part of a comprehensive treatment plan.

GNH USA supplies Levodopa/Carbidopa/Entacapone Kern Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our network ensures reliable delivery and regulatory compliance across multiple regions.

Levodopa/Carbidopa/Entacapone is used in the management of Parkinson's disease, targeting dopaminergic pathways to improve motor symptoms. - Parkinson's disease (early to advanced stages): improves motor function and reduces off‑time. - Parkinson's disease with motor fluctuations: provides more stable dopamine levels. - Parkinson's disease (adjunct to levodopa therapy): enhances levodopa efficacy and prolongs its action.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness: sensation of light‑headedness, especially on standing. - Orthostatic hypotension: drop in blood pressure upon standing. - Headache: transient cranial discomfort. - Insomnia: difficulty initiating or maintaining sleep. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements. - Severe hypotension: marked blood pressure decline requiring medical attention. - Hallucinations or psychosis: visual or auditory disturbances. - Neuroleptic malignant syndrome: rare but life‑threatening reaction. - Cardiac arrhythmias: irregular heart rhythm. - Severe liver injury: abnormal liver function tests or jaundice.

Levodopa/Carbidopa/Entacapone requires careful monitoring to ensure safe use. - Monitor blood pressure: check for orthostatic changes, especially after dose adjustments. - Assess for dyskinesia: watch for involuntary movements and modify therapy if needed. - Review hepatic function: obtain baseline liver enzymes before initiating therapy. - Avoid abrupt discontinuation: taper under medical supervision to prevent withdrawal effects. - Pregnancy and lactation: use only if potential benefits outweigh potential risks. - Store at ambient temperature: keep in original container, protect from moisture and light.

Levodopa/Carbidopa/Entacapone may interact with several medicines, requiring attention to avoid adverse outcomes. Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - High‑dose pyridoxine (vitamin B6): reduces levodopa efficacy. - Anticholinergic agents: may worsen confusion and cognitive impairment. Moderate Interactions (Monitor Closely): - SSRIs or SNRIs: potential for serotonin syndrome. - Diuretics: may enhance orthostatic hypotension. - Antihypertensive drugs: additive blood‑pressure‑lowering effect.